MedPath

Motor Imagery Plus Therapeutic Exercise in Women With Menstrual Pain

Not Applicable
Not yet recruiting
Conditions
Motor Imagery Training
Registration Number
NCT06674655
Lead Sponsor
University of Valencia
Brief Summary

The researchers will conduct a study that combines motor imagery with therapeutic exercise in women experiencing menstrual pain. Previous research suggests that motor imagery, when used alongside physical exercise, may help improve motor control and alleviate pain, potentially enhancing outcomes for individuals dealing with chronic pain conditions. Through this study, the investigators aim to explore the effectiveness of these interventions in targeting key variables such as pain perception, motor coordination, and overall quality of life, building on existing evidence of motor imagery's benefits in pain management.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
48
Inclusion Criteria
  • Women who have experienced menstrual pain for more than 6 months.
  • Pain intensity rated higher than 3/10 on a pain scale.
  • Participants do not take pain-relief medication during the study period.
  • Ages between 18 and 35 years old
Exclusion Criteria
  • Current use of hormonal contraceptives or other treatments that affect menstrual cycles.
  • Any chronic pain condition unrelated to menstrual pain (e.g., fibromyalgia, chronic low back pain).
  • Diagnosed gynecological conditions such as endometriosis or pelvic inflammatory disease.
  • Pregnancy or breastfeeding.
  • Current use of psychoactive medications that could affect pain perception.
  • Any significant psychiatric condition that could interfere with study participation.
  • History of recent pelvic surgery (within the last 6 months).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Pain IntensityMenstrual pain intensity will be assessed pre-intervention (T0), mid-intervention (T1-day 1, T2-day 2) and Post-intervention (T3-day 3).

The main variable is the intensity of menstrual pain, which will be evaluated before, during and after the intervention using a verbal numerical scale (0-10), where 0 is no pain and 10 is maximum pain.

Secondary Outcome Measures
NameTimeMethod
Lumbopelvic Motor ControlLumbopelvic motor control will be assessed pre-intervention (T0), mid-intervention (T1-day 1, T2-day 2) and Post-intervention (T3-day 3).

Lumbopelvic motor control will be assessed by a visual feedback system starting from a pressure of 40 mmHg.

Pain SensitivityPain sensitivity will be assessed pre-intervention (T0), mid-intervention (T1-day 1, T2-day 2) and Post-intervention (T3-day 3).

Pain sensitivity will be assessed with an algometer using pressure pain thresholds (in various areas, such as the abdomen, lumbar and thiabial region), as well as through conditioned pain modulation.

Trial Locations

Locations (1)

University of Valencia

🇪🇸

València, Valènica, Spain

© Copyright 2025. All Rights Reserved by MedPath